Murphy & Mullick Capital Management’s Idexx Laboratories IDXX Stock Holding History

Murphy & Mullick Capital Management’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$14K	Buy	+25	New	+$16K	0.01%	436

Other funds holding IDXX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Murphy & Mullick Capital Management's IDXX Position: Q1 2026 in Review

Murphy & Mullick Capital Management opened a new position in Idexx Laboratories (IDXX) in Q1 2026: 25 shares worth $14K. The stake represents 0.01% of the portfolio and ranks #436 among its holdings.

1,311 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.

Murphy & Mullick Capital Management held 25 shares of Idexx Laboratories worth $14K as of Q1 2026.
Idexx Laboratories was a new Murphy & Mullick Capital Management position in Q1 2026.
Idexx Laboratories made up 0.01% of Murphy & Mullick Capital Management's portfolio in Q1 2026, its #436 holding.
1,311 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.

Based on Murphy & Mullick Capital Management's 13F filing for Q1 2026, filed 17 Apr 2026.